Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

Osteoporosis drug romosozumab posts positive topline results in Phase 3 trial in postmenopausal women

October 6, 2022
admin
The drug romosozumab has posted positive results in the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME) trial, according to UCB and Amgen.

Level of education crucial to understanding atrial fibrillation risk, new survey reveals

October 6, 2022
admin
Patients with higher education benefit more from blood thinning medications, a new study by the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) has revealed.

First European advice on acute heart failure launched

October 6, 2022
admin
The first European advice on emergency care for patients with acute heart failure has been published in European Heart Journal: Acute Cardiovascular Care.

New MS campaign targets patients ‘lost to follow-up’

October 6, 2022
admin
A new survey has highlighted that the lack of engagement with specialist services of some patients with multiple sclerosis (MS) is a concern for MS-specialists.

Collaborative research key to improving ovarian cancer treatments, analyst says

October 6, 2022
admin
The recent announcement that Merck and ImmunoGen will partner to investigate a combination of their respective drugs, Keytruda and mirvetuximab soravtansine, for the treatment of ovarian cancer, will "open the way to unlocking the potential of combining novel immuno-oncology (IO) and non-IO drugs", according to a specialist oncology analyst.

Analyst says collaborative research key to improving ovarian cancer treatments

October 6, 2022
admin
The recent announcement that Merck and ImmunoGen will partner to investigate a combination of their respective drugs, Keytruda and mirvetuximab soravtansine, for the treatment of ovarian cancer, will "open the way to unlocking the potential of combining novel immuno-oncology (IO) and non-IO drugs", according to a specialist oncology analyst.

New MS campaign targets patients ‘lost to follow-up’

October 6, 2022
admin
A new survey has highlighted that the lack of engagement with specialist services of some patients with multiple sclerosis (MS) is a concern for MS-specialists.

Smoking linked to cervical spine disease

October 6, 2022
admin
Smoking has been linked to a worsening degenerative disc disease in the cervical spine, researchers at Emory University in Atlanta, Georgia, have announced.

Alterations in brain wiring could be responsible for link between childhood IQ, low birthweight and psychosis, researchers claim

October 6, 2022
admin
Microscopic alterations in brain wiring within regions of the brain that underlie reasoning and awareness could be responsible for the association between childhood IQ, low birthweight and later psychotic experiences, new research has claimed.

PRAC completes three drug safety reviews

October 6, 2022
admin
The European Medicine Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded three reviews into the drug safety at its February meeting.

UK cancer cases soar to 352,000 each year

October 6, 2022
admin
More than 352,000 people are diagnosed with cancer in the UK each year, 12% increase in the rate since the mid-nineties, according to new figures released by Cancer Research UK.

Ovarian cancer: Latest news update

October 6, 2022
Alison Bloomer
Around 7,100 women are diagnosed in the UK with ovarian cancer each year. Read the latest on developments in the diagnosis and management of ovarian cancer.

Women over 65 with high sex drives don’t let health issues get in their way

October 6, 2022
admin
While men over 65 are more than twice as likely to think about sex at least once a week than women are, those women who do think about sex regularly are more likely to engage in sexual activity, and don't let ill health stop them.

Membership of social groups after retirement boosts health and wellbeing’

October 6, 2022
admin
New research published by the BMJ suggests that membership of social groups such as book clubs or church groups after retirement is linked with improved health and wellbeing. 

Smoking and inactivity linked to rise in heart attack among young men

October 6, 2022
admin
Men who smoke and lead an inactive lifestyle have an increased risk of suffering a heart attack, according to a study by doctors in India.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy